BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Olejnik J, Forero A, Deflubé LR, Hume AJ, Manhart WA, Nishida A, Marzi A, Katze MG, Ebihara H, Rasmussen AL, Mühlberger E. Ebolaviruses Associated with Differential Pathogenicity Induce Distinct Host Responses in Human Macrophages. J Virol 2017;91:e00179-17. [PMID: 28331091 DOI: 10.1128/JVI.00179-17] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 6.2] [Reference Citation Analysis]
Number Citing Articles
1 Valdés-lópez JF, Fernandez GJ, Urcuqui-inchima S. Synergistic Effects of Toll-Like Receptor 1/2 and Toll-Like Receptor 3 Signaling Triggering Interleukin 27 Gene Expression in Chikungunya Virus-Infected Macrophages. Front Cell Dev Biol 2022;10:812110. [DOI: 10.3389/fcell.2022.812110] [Reference Citation Analysis]
2 McElroy AK, Mühlberger E, Muñoz-Fontela C. Immune barriers of Ebola virus infection. Curr Opin Virol 2018;28:152-60. [PMID: 29452995 DOI: 10.1016/j.coviro.2018.01.010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
3 Zhang M, Wang X, Hu L, Zhang Y, Zheng H, Wu H, Wang J, Luo L, Xiao H, Qiao C, Li X, Huang W, Wang Y, Feng J, Chen G. TIM-1 Augments Cellular Entry of Ebola Virus Species and Mutants, Which Is Blocked by Recombinant TIM-1 Protein. Microbiol Spectr 2022;:e0221221. [PMID: 35384693 DOI: 10.1128/spectrum.02212-21] [Reference Citation Analysis]
4 Perez-Zsolt D, Martinez-Picado J, Izquierdo-Useros N. When Dendritic Cells Go Viral: The Role of Siglec-1 in Host Defense and Dissemination of Enveloped Viruses. Viruses 2019;12:E8. [PMID: 31861617 DOI: 10.3390/v12010008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
5 Edenborough KM, Bokelmann M, Lander A, Couacy-Hymann E, Lechner J, Drechsel O, Renard BY, Radonić A, Feldmann H, Kurth A, Prescott J. Dendritic Cells Generated From Mops condylurus, a Likely Filovirus Reservoir Host, Are Susceptible to and Activated by Zaire Ebolavirus Infection. Front Immunol 2019;10:2414. [PMID: 31681302 DOI: 10.3389/fimmu.2019.02414] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
6 Diallo I, Ho J, Laffont B, Laugier J, Benmoussa A, Lambert M, Husseini Z, Soule G, Kozak R, Kobinger GP, Provost P. Altered microRNA Transcriptome in Cultured Human Liver Cells upon Infection with Ebola Virus. Int J Mol Sci 2021;22:3792. [PMID: 33917562 DOI: 10.3390/ijms22073792] [Reference Citation Analysis]
7 Bodmer BS, Greßler J, Schmidt ML, Holzerland J, Brandt J, Braun S, Groseth A, Hoenen T. Differences in Viral RNA Synthesis but Not Budding or Entry Contribute to the In Vitro Attenuation of Reston Virus Compared to Ebola Virus. Microorganisms 2020;8:E1215. [PMID: 32796523 DOI: 10.3390/microorganisms8081215] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
8 Chambers BS, Heaton BE, Rausch K, Dumm RE, Hamilton JR, Cherry S, Heaton NS. DNA mismatch repair is required for the host innate response and controls cellular fate after influenza virus infection. Nat Microbiol 2019;4:1964-77. [PMID: 31358986 DOI: 10.1038/s41564-019-0509-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
9 Farman MR, Hofacker IL, Amman F. MSF: Modulated Sub-graph Finder. F1000Res 2018;7:1346. [PMID: 30984370 DOI: 10.12688/f1000research.16005.3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Olejnik J, Hume AJ, Leung DW, Amarasinghe GK, Basler CF, Mühlberger E. Filovirus Strategies to Escape Antiviral Responses. Curr Top Microbiol Immunol 2017;411:293-322. [PMID: 28685291 DOI: 10.1007/82_2017_13] [Cited by in Crossref: 6] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
11 Basler CF. Molecular pathogenesis of viral hemorrhagic fever. Semin Immunopathol 2017;39:551-61. [PMID: 28555386 DOI: 10.1007/s00281-017-0637-x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 32] [Article Influence: 8.2] [Reference Citation Analysis]
12 Price A, Caciula A, Guo C, Lee B, Morrison J, Rasmussen A, Lipkin WI, Jain K. DEvis: an R package for aggregation and visualization of differential expression data. BMC Bioinformatics 2019;20:110. [PMID: 30832568 DOI: 10.1186/s12859-019-2702-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
13 Hargreaves A, Brady C, Mellors J, Tipton T, Carroll MW, Longet S. Filovirus Neutralising Antibodies: Mechanisms of Action and Therapeutic Application. Pathogens 2021;10:1201. [PMID: 34578233 DOI: 10.3390/pathogens10091201] [Reference Citation Analysis]
14 Hekman RM, Hume AJ, Goel RK, Abo KM, Huang J, Blum BC, Werder RB, Suder EL, Paul I, Phanse S, Youssef A, Alysandratos KD, Padhorny D, Ojha S, Mora-Martin A, Kretov D, Ash PEA, Verma M, Zhao J, Patten JJ, Villacorta-Martin C, Bolzan D, Perea-Resa C, Bullitt E, Hinds A, Tilston-Lunel A, Varelas X, Farhangmehr S, Braunschweig U, Kwan JH, McComb M, Basu A, Saeed M, Perissi V, Burks EJ, Layne MD, Connor JH, Davey R, Cheng JX, Wolozin BL, Blencowe BJ, Wuchty S, Lyons SM, Kozakov D, Cifuentes D, Blower M, Kotton DN, Wilson AA, Mühlberger E, Emili A. Actionable Cytopathogenic Host Responses of Human Alveolar Type 2 Cells to SARS-CoV-2. Mol Cell 2020;80:1104-1122.e9. [PMID: 33259812 DOI: 10.1016/j.molcel.2020.11.028] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 10.0] [Reference Citation Analysis]
15 Sadewasser A, Dietzel E, Michel S, Klüver M, Helfer M, Thelemann T, Klar R, Eickmann M, Becker S, Jaschinski F. Anti-Niemann Pick C1 Single-Stranded Oligonucleotides with Locked Nucleic Acids Potently Reduce Ebola Virus Infection In Vitro. Mol Ther Nucleic Acids 2019;16:686-97. [PMID: 31125846 DOI: 10.1016/j.omtn.2019.04.018] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
16 Olejnik J, Hume AJ, Mühlberger E. Toll-like receptor 4 in acute viral infection: Too much of a good thing. PLoS Pathog 2018;14:e1007390. [PMID: 30571771 DOI: 10.1371/journal.ppat.1007390] [Cited by in Crossref: 61] [Cited by in F6Publishing: 58] [Article Influence: 15.3] [Reference Citation Analysis]
17 McElroy AK, Akondy RS, Mcllwain DR, Chen H, Bjornson-Hooper Z, Mukherjee N, Mehta AK, Nolan G, Nichol ST, Spiropoulou CF. Immunologic timeline of Ebola virus disease and recovery in humans. JCI Insight 2020;5:137260. [PMID: 32434986 DOI: 10.1172/jci.insight.137260] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
18 McElroy AK, Shrivastava-Ranjan P, Harmon JR, Martines RB, Silva-Flannery L, Flietstra TD, Kraft CS, Mehta AK, Lyon GM, Varkey JB, Ribner BS, Nichol ST, Zaki SR, Spiropoulou CF. Macrophage Activation Marker Soluble CD163 Associated with Fatal and Severe Ebola Virus Disease in Humans1. Emerg Infect Dis 2019;25:290-8. [PMID: 30666927 DOI: 10.3201/eid2502.181326] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
19 Stefan CP, Arnold CE, Shoemaker CJ, Zumbrun EE, Altamura LA, Douglas CE, Taylor-Howell CL, Graham AS, Delp KL, Blancett CD, Ricks KM, Olschner SP, Shamblin JD, Wollen SE, Zelko JM, Bloomfield HA, Sprague TR, Esham HL, Minogue TD. Transcriptomic Analysis Reveals Host miRNAs Correlated with Immune Gene Dysregulation during Fatal Disease Progression in the Ebola Virus Cynomolgus Macaque Disease Model. Microorganisms 2021;9:665. [PMID: 33806942 DOI: 10.3390/microorganisms9030665] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 Olukitibi TA, Ao Z, Mahmoudi M, Kobinger GA, Yao X. Dendritic Cells/Macrophages-Targeting Feature of Ebola Glycoprotein and its Potential as Immunological Facilitator for Antiviral Vaccine Approach. Microorganisms 2019;7:E402. [PMID: 31569539 DOI: 10.3390/microorganisms7100402] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
21 Deflubé LR, Cressey TN, Hume AJ, Olejnik J, Haddock E, Feldmann F, Ebihara H, Fearns R, Mühlberger E. Ebolavirus polymerase uses an unconventional genome replication mechanism. Proc Natl Acad Sci U S A 2019;116:8535-43. [PMID: 30962389 DOI: 10.1073/pnas.1815745116] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
22 Speranza E, Connor JH. Host Transcriptional Response to Ebola Virus Infection. Vaccines (Basel) 2017;5:E30. [PMID: 28930167 DOI: 10.3390/vaccines5030030] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
23 Terruzzi I, Senesi P. Does intestinal dysbiosis contribute to an aberrant inflammatory response to severe acute respiratory syndrome coronavirus 2 in frail patients? Nutrition 2020;79-80:110996. [PMID: 33002653 DOI: 10.1016/j.nut.2020.110996] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
24 Spengler JR, Saturday G, Lavender KJ, Martellaro C, Keck JG, Nichol ST, Spiropoulou CF, Feldmann H, Prescott J. Severity of Disease in Humanized Mice Infected With Ebola Virus or Reston Virus Is Associated With Magnitude of Early Viral Replication in Liver. J Infect Dis 2017;217:58-63. [PMID: 29087482 DOI: 10.1093/infdis/jix562] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 6.3] [Reference Citation Analysis]
25 Reynard S, Journeaux A, Gloaguen E, Schaeffer J, Varet H, Pietrosemoli N, Mateo M, Baillet N, Laouenan C, Raoul H, Mullaert J, Baize S. Immune parameters and outcomes during Ebola virus disease. JCI Insight 2019;4:125106. [PMID: 30626757 DOI: 10.1172/jci.insight.125106] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 5.7] [Reference Citation Analysis]
26 Escudero-Pérez B, Muñoz-Fontela C. Role of Type I Interferons on Filovirus Pathogenesis. Vaccines (Basel) 2019;7:E22. [PMID: 30791589 DOI: 10.3390/vaccines7010022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
27 Bosworth A, Dowall SD, Armstrong S, Liu X, Dong X, Bruce CB, F P Ng L, Carroll MW, Hewson R, Hiscox JA. Investigating the Cellular Transcriptomic Response Induced by the Makona Variant of Ebola Virus in Differentiated THP-1 Cells. Viruses 2019;11:E1023. [PMID: 31689981 DOI: 10.3390/v11111023] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
28 Yamaoka S, Ebihara H. Pathogenicity and Virulence of Ebolaviruses with Species- and Variant-specificity. Virulence 2021;12:885-901. [PMID: 33734027 DOI: 10.1080/21505594.2021.1898169] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
29 Cantoni D, Rossman JS. Ebolaviruses: New roles for old proteins. PLoS Negl Trop Dis 2018;12:e0006349. [PMID: 29723187 DOI: 10.1371/journal.pntd.0006349] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 4.5] [Reference Citation Analysis]